dc.contributor.author |
El Aouad, Noureddine
|
es_ES |
dc.contributor.author |
Berenguer, Inmaculada
|
es_ES |
dc.contributor.author |
Romero, Vanessa
|
es_ES |
dc.contributor.author |
Marin, Paloma
|
es_ES |
dc.contributor.author |
Serrano, Angel
|
es_ES |
dc.contributor.author |
Andujar, Sebastian
|
es_ES |
dc.contributor.author |
Suvire, Fernando
|
es_ES |
dc.contributor.author |
Bermejo, Almudena
|
es_ES |
dc.contributor.author |
Ivorra, M. Dolores
|
es_ES |
dc.contributor.author |
Enriz, Ricardo D.
|
es_ES |
dc.contributor.author |
Cabedo Escrig, Nuria
|
es_ES |
dc.contributor.author |
Cortes, Diego
|
es_ES |
dc.date.accessioned |
2016-07-08T10:58:16Z |
|
dc.date.available |
2016-07-08T10:58:16Z |
|
dc.date.issued |
2009-11 |
|
dc.identifier.issn |
0223-5234 |
|
dc.identifier.uri |
http://hdl.handle.net/10251/67377 |
|
dc.description.abstract |
Two series of halogenated 1-benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolines were prepared to explore the influence of each series on the affinity for dopamine receptors. All the compounds displayed a high affinity for D(1)-like and/or D(2)-like dopamine receptors in striatal membranes, although they were unable to inhibit [(3)H]-dopamine uptake in striatal synaptosomes. The halogen placed on the benzylic ring in 1-benzyl-THIQs, compounds of the series 1, 2'-bromobenzyl derivatives with K(i) values into the nanomolar range, and the series 2, 2',4'-dichlorobenzyl-THIQ homologues, proves to be an important factor to modulate affinity at dopamine receptor. (C) 2009 Elsevier Masson SAS. All rights reserved. |
es_ES |
dc.description.sponsorship |
This research was supported by the Spanish "Ministerio de Educacion y Ciencia" grant SAF 2007-63142. I. Berenguer acknowledges the fellowship of Generalitat Valenciana. S. Andujar acknowledges the fellowship of CONICET-Argentina. |
en_EN |
dc.language |
Inglés |
es_ES |
dc.publisher |
Elsevier |
es_ES |
dc.relation |
Spanish "Ministerio de Educacion y Ciencia" SAF 2007-63142 |
es_ES |
dc.relation |
Generalitat Valenciana |
es_ES |
dc.relation |
CONICET-Argentina |
es_ES |
dc.relation.ispartof |
European Journal of Medicinal Chemistry |
es_ES |
dc.rights |
Reserva de todos los derechos |
es_ES |
dc.subject |
1-Halogenated benzyl-7-chloro-6-hydroxytetrahydroisoquinolines |
es_ES |
dc.subject |
Binding |
es_ES |
dc.subject |
Dopamine receptors |
es_ES |
dc.subject |
Dopamine uptak |
es_ES |
dc.subject |
Structure–activity relationships |
es_ES |
dc.title |
Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives |
es_ES |
dc.type |
Artículo |
es_ES |
dc.identifier.doi |
10.1016/j.ejmech.2009.06.033 |
|
dc.rights.accessRights |
Cerrado |
es_ES |
dc.contributor.affiliation |
Universitat Politècnica de València. Instituto Agroforestal Mediterráneo - Institut Agroforestal Mediterrani |
es_ES |
dc.description.bibliographicCitation |
El Aouad, N.; Berenguer, I.; Romero, V.; Marin, P.; Serrano, A.; Andujar, S.; Suvire, F.... (2009). Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives. European Journal of Medicinal Chemistry. 44(11):4616-4621. doi:10.1016/j.ejmech.2009.06.033 |
es_ES |
dc.description.accrualMethod |
S |
es_ES |
dc.relation.publisherversion |
http://dx.doi.org/10.1016/j.ejmech.2009.06.033 |
es_ES |
dc.description.upvformatpinicio |
4616 |
es_ES |
dc.description.upvformatpfin |
4621 |
es_ES |
dc.type.version |
info:eu-repo/semantics/publishedVersion |
es_ES |
dc.description.volume |
44 |
es_ES |
dc.description.issue |
11 |
es_ES |
dc.relation.senia |
38606 |
es_ES |